Home
Screener
Insiders
Rankings
Sign in
Create account
Insiders
· Profile
Campbell David Alan
President and CEO at Janux Therapeutics. Filing since 27 Sep 2024.
CIK 0001864158
Company
Date
Role
Action
Shares
Amount
Of holding
JANX
Janux Therapeutics, Inc.
2 Jan 2026
President and CEO
Sold at will
8,072
$110.83K
2.8%
JANX
Janux Therapeutics, Inc.
7 Jan 2025
President and CEO
Sold on a plan
5,000
$300.00K
1.7%
JANX
Janux Therapeutics, Inc.
24 Dec 2024
President and CEO
Sold on a plan
25,000
$1.40M
10.3%
JANX
Janux Therapeutics, Inc.
3 Dec 2024
President and CEO
Sold on a plan
15,000
$1.01M
5.8%
JANX
Janux Therapeutics, Inc.
25 Nov 2024
President and CEO
Sold on a plan
25,000
$1.29M
8.9%
JANX
Janux Therapeutics, Inc.
28 Oct 2024
President and CEO
Sold on a plan
25,000
$1.34M
8.1%
JANX
Janux Therapeutics, Inc.
27 Sep 2024
President and CEO
Sold on a plan
25,000
$1.16M
7.5%
7 decisions on file.
